Clinical Trial Update: Delayed CNI-based Immunosuppression With Advagraf After MELD-based Liver Transplantation

View source ↗

Summary

Clinical trial update on delaying calcineurin inhibitor-based immunosuppression with Advagraf after MELD-based liver transplantation. It addresses liver graft d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Graft Dysfunction

Drugs mentioned

• Advagraf (tacrolimus)

Snippet

Sponsor: Heidelberg University | Conditions: Liver Graft Dysfunction | Status: UNKNOWN